Proliferation of resident glomerular cells and the accumulation of mesangial matrix are histologic abnormalities which are observed in the course of many progressive glomerular diseases. We explored the potential regulatory effects of transforming growth factor-, (TGF-,#) on these processes. We found that cultured mouse glomerular endothelial, mesangial, and epithelial cells as well as isolated intact rat glomeruli pos- 
Introduction
Proliferation of resident glomerular cells and/or the accumulation of mesangial matrix constitute the first discernable glomerular morphologic abnormalities in several different renal diseases (1) (2) (3) (4) (5) (6) . This suggests that dysregulation of factors that control glomerular cell proliferation and mesangial matrix accumulation may play an early and perhaps critical role in the cascade of events leading to a loss ofglomerular structural and functional integrity. Recently, several investigators have used cultured glomerular cells to define the responses of individual glomerular cell types to potential regulatory or pathogenic stimuli. These studies demonstrated that mesangial cells exhibit a proliferative response to platelet-derived growth factor heparin species exhibit a negative effect on mesangial cell proliferation (1 1, 12) .
One potentially important modulator of glomerular cell function whose effects on resident glomerular cells remain unexplored is transforming growth factor-,B (TGF-fl). The TGFs were originally defined as peptides that reversibly confer the transformed phenotype on cultured fibroblasts. Isolation and purification of one of the TGFs, TGF-f, revealed it to be a disulfide-linked homodimer of 25,000 mol wt that is present in several normal and neoplastic tissues (13). The highest concentration of TGF-,B is found in platelets which release it during degranulation (14) . This peptide has potent effects on the proliferation and differentiation of a variety of cell types as well as on synthesis of extracellular matrix components. Generally TGF-3 has been found to inhibit the proliferation of cultured cells; however, it may also act as a proliferative stimulus to some of the same cell types under different culture conditions (15, 16) . TGF-,B also acts as a bifunctional regulator of differentiation in that it stimulates the differentiation of normal human bronchial epithelial cells (17) but inhibits the differentiation of myoblasts (18). In addition, TGF-f, increases the synthesis of collagen by fibroblasts (19) and osteoblasts (20) and increases fibronectin synthesis in a variety of normal and transformed cell types (21) . The effects of TGF-,B on fibronectin synthesis appear to be somewhat dependent on cell type inasmuch as no increase in fibronectin synthesis was noted in aortic smooth muscle cells exposed to TGF-,3 (16) .
Since TGF-# is present in normal kidney (22) and since platelet and platelet antigens have been found within the glomerulus in a number of renal diseases (23) (24) (25) , it is likely that glomerular cells are exposed to TGF-f3. In these studies we demonstrate the presence of high-affinity TGF-,# receptors on cultured mouse glomerular endothelial, mesangial, and epithelial cells as well as on isolated rat glomeruli. In addition, the effects of TGF-,B on glomerular cell proliferation and on the production of collagen and fibronectin synthesized by mesangial and epithelial cells are described.
Methods
Isolation and identification ofmouse glomerular cells. Glomerular endothelial, mesangial, and epithelial cells were cultured from glomeruli isolated from normal 4-wk-old mice (C57BI/6J X SJL/J) using techniques previously described (26) . Pure populations of cells were obtained using the techniques of dilute plating and patch cloning. Endothelial and mesangial cells were maintained in basal medium supplemented with 20% FBS. Basal medium consisted of a 3:1 mixture of MEM/F12 modified with trace elements as described (26) , to which glutamine, penicillin, and streptomycin were added. Epithelial cells were maintained in basal medium supplemented with 2% FBS. Cells were subcultured two to three times weekly at a 1:4 split ratio. All culture dishes and flasks were coated with a thin layer of 200 Ag/ml human fibronectin (Collaborative Research, Inc., Lexington, MA). All experiments were performed on cells between passages 8 and 20. Culture morphology and homogeneity were preserved at all passages tested. Results were verified on a second independently isolated population of each cell type and were qualitatively identical and quantitatively similar.
Identification ofcells. Immunofluorescence staining was performed as described (26) . Immunofluorescence staining for PHM5 (Bioscience Products AG, Emmenbrucke, Switzerland) was performed on cells fixed with paraformaldehyde at 4VC for 20 min. Cells were incubated with normal goat serum for 20 min followed by an incubation with a 1:3 dilution of PHM5 (27). Cells were then washed with phosphatebuffered saline incubated with biotin-conjugated goat anti-mouse IgG (Tago Inc., Burlingame, CA) washed, incubated with FITC-conjugated streptavidin (Zymed, San Francisco, CA) washed, mounted, and examined.
Assays for alkaline phosphatase and y-glutamyl-transpeptidase were performed on subconfluent cultures of glomerular epithelial cells as described (26) . LLC-PKl cells (ATCC CRL 1392) served as a positive control. Cells were evaluated for the uptake of acetylated LDL as described (28, 29) .
Binding assayfor cells. Binding of 1251-labeled TGF-i3 to near-confluent monolayers of individual glomerular cell types was determined as described (30, 31). For these assays 5-7 X 104 cells were plated per well in 24-well cluster plates in basal medium supplemented with 10% FBS for endothelial and mesangial cells and 2% FBS for epithelial cells. Purified TGF-(B was isolated from human platelets and iodinated as described (30).
The decrease in TCA precipitability of the labeled ligand after the 2-h incubation with the monolayers was < 4%. Values for free and bound radioactivity were determined on duplicate wells which typically differed by . 7%.
For displacement experiments, total and nonspecific binding were allowed to reach equilibrium during a 90-min incubation at 22°C. Labeled ligand was added at a concentration of 50 pM. Nonspecific binding was determined in wells containing a 100-fold excess of unlabeled ligand. After the 90-min incubation (time zero) binding media were removed, the cells were washed twice with fresh binding medium, and the medium was replaced with binding medium containing 5 nM unlabeled TGF-,B. Displacement was determined as the decrement in specifically bound counts over time compared to the amount of specific binding present at time zero. 80% of the displaced counts were precipitable with TCA after a 3-h displacement period.
Binding assay on intact glomeruli. Female Sprague-Dawley rats weighing approximately 250 g were anesthetized with a subcutaneous injection of Innovar-Vet (Pitman-Moore Inc., Washington Crossing, NJ). Glomeruli were isolated (using 190-and 74-Am sieves from E-C Apparatus Corp., St. Petersburg, FL) from kidneys which had been flushed free of blood with binding buffer. Isolated glomeruli were incubated with constant rotation in binding buffer for 1 h at 37°C. Glomerular number and purity were determined by counting three separate 2-ml aliquots of this glomerular suspension using a scored counting chamber under phase contrast microscopy. Counts consistently differed by . 15%. Glomerular preparations were 90-95% pure and contained over 90% decapsulated glomeruli. Aliquots containing 150 glomeruli were centrifuged (25 g for 1 min). Medium was replaced with 0.5 ml of binding buffer containing varying amounts of 125I-labeled TGF-,B with or without 10 nM unlabeled TGF-#. After a 2-h incubation with constant rotation at room temperature the glomeruli were briefly centrifuged, the media removed, the glomeruli washed four times in wash buffer and the glomerular pellet was counted in a gamma counter. The binding media and the first wash were pooled and counted to determine the free ligand concentration.
TCA precipitability of the labeled ligand incubated with glomeruli decreased by . 2% during the assay. Values for free and bound radioactivity were determined on duplicate samples. These values typically differed by . 7%. Time course and displacement assays for glomerular binding were performed as described above.
Effect of TGF-4 on FBS stimulated glomerular cell proliferation.
On day zero, 1 X 104 cells were plated in each well of 24-well cluster plates in basal medium supplemented with 2% FBS. After 6-8 h of incubation TGF-# was added to the wells at the indicated concentrations. Cells in three to four replicate wells were trypsinized and counted using an ELZONER electronic particle counter (Particle Data Inc., Elmhurst, IL).
Thymidine incorporation assays. Cells were plated at 2.5-5 X 104 per well in 24-well plates in medium containing 10% (endothelial and mesangial cells) or 2% FBS (epithelial cells). At 24 h cells were washed and the medium changed to serum-free medium. This medium was replaced every 24 h until no increase in cell number over 24 24 -well cluster plates in basal medium supplemented with 2% FBS. 8 h later TGF-,B was added to a final concentration of 10 pM to one of the plates. Cell number in triplicate or quadruplicate wells was determined after 36 h as described above.
Collagen production. Mesangial cells were plated at 2 X 105 cells per well in six-well cluster plates in basal medium supplemented with 10% FBS. After 24 h the cells were washed with basal medium and incubated in basal medium with 0.2% FBS. After 12 h medium was again changed to fresh medium containing 0.2% FBS to which varying concentrations ofTGF-(B was added. After an additional 12 h medium was changed to proline-free medium with 0.2% FBS, the indicated amount ofTGF-,B, 25 mM ascorbic acid (Sigma Chemical Co., St. Louis, MO), and 5 ,uCi of L-[2,3-3H]proline (Amersham Corp.). After 5 h the medium and cells were harvested and assessed for collagen production as described (20, 32) using chromatographically purified bacterial collagenase (Advance Biofactures, Lynbrook, NY). Collagen production was determined on medium and monolayers collected from triplicate wells which were processed separately. Cell number was determined on duplicate wells at each TGF-(# concentration tested. Monolayers contained < 10% of total collagenase sensitive protein and exhibited no change in response to TGF-f3.
Collagen production in near confluent cultures of glomerular epithelial cells was assessed as described for mesangial cells except that the epithelial cells were plated in 2% rather than 10% FBS.
Fibronectin synthesis. Cells were plated and medium changes performed as described for collagen production assays. After 12 h of incubation with different concentrations of TGF-,B, the medium was changed to cysteine-free medium containing 0.2% FBS, the indicated amount ofTGF-,B, and 20 ,Ci of t5S]cysteine (Amersham Corp.). The cells were labeled for 3 h, after which the medium and cell layers were processed as described (21) except that rabbit anti-mouse fibronectin (Biomedical Technologies, Inc., Stoughton, MA) was used for the immunoprecipitation studies. Cell counts were determined on duplicate wells at each concentration of TGF-#. The Fig. 5 , proliferation of mesangial cells plated at low density (as they were for the experiments described above) was inhibited by the addition of TGF-fl while cells at higher density exhibited a proliferative response to TGF-j3. Neither glomerular endothelial nor glomerular epithelial cells evidenced a proliferative response to TGF-j3 when tested under identical conditions. TGF-3 induced a morphologic change in serum-depleted mesangial cells. Mesangial cells characteristically have an elongated, spindle shape when grown with high concentrations of serum. At low serum concentrations (< 5% FBS) they assumed a more cuboidal morphology. The addition of TGF-3 to these cells resulted in the prompt (< 12 h) return to the typical elongated mesangial cell morphology (Fig. 6 ). This morphologic alteration was noted in both sparse and near confluent cells.
Effects of TGF-0 on glomerular collagen and fibronectin production. Along with its effects on proliferation and morphology, TGF-f3 increased the production of collagen and fibronectin synthesized by glomerular mesangial cells. The addition of TGF-13 resulted in a twofold increase in the amount of collagenase sensitive protein in the medium of mesangial cells (Table II) . TGF-,3 also significantly increased the production of fibronectin by mesangial cells (Fig. 7) . TGF-f3 failed to augment collagen production by glomerular epithelial cells but did cause a substantial increase in epithelial cell fibronectin production (Fig. 8) .
Discussion
The present study reports the presence of receptors for TGF-,3 on intact glomeruli and on isolated glomerular endothelial, mesangial, and epithelial cells. The effects of TGF-,3 on glomerular cell proliferation and extracellular matrix production were also explored.
We found that cultured mouse glomerular endothelial, mesangial, and epithelial cells possess TGF-3 receptors of similar high affinity (Kd = 5, 5, 9 pM, respectively). Furthermore, high-affinity TGF-j3 receptors were also demonstrated on isolated rat glomeruli. The receptors on intact glomeruli were of somewhat lower affinity than those of cultured mouse cells (Kd = 20, 24, 37 pM in three separate experiments).
The significance of the finding of TGF-,3 receptors on glomeruli was that, heretofore, TGF-,3 receptors have only been demonstrated on isolated cells. The presence of TGF-,3 receptors on glomeruli adds significant support to the hypothesis that TGF-# is a potent modulator of cell behavior in vivo as well as in vitro. Further studies will be required to determine whether the differences in TGF-# receptor affinity in cultured glomerular cells and isolated glomeruli reflect species differences or alterations in TGF-,3 receptor affinity in the cultured cells.
Since proliferation of resident glomerular cells and accumulation of mesangial matrix material are prominent histologic findings in several progressive glomerular diseases (1) (2) (3) (4) (5) (6) TGF-jB could be provided to the glomerulus in vivo from a number of sources. One likely source is platelets which release TGF-#t during degranulation (14) . Platelets are a particularly rich source of TGF-,6 as they contain approximately 100-fold more TGF-# than other cells or tissues examined to date. A number of factors combine to indicate a role of platelets or platelet products in the pathogenesis or glomerular lesions. Platelets, platelet antigens, or platelet-derived inflammatory products have been identified within the glomerulus in both immune and nonimmune mediated glomerular diseases (23) (24) (25) . In addition, agents expected to decrease glomerular deposition of platelets and platelet aggregation have been shown to have a beneficial effect on the progression of the glomerulosclerosis observed in animals subjected to partial nephrectomy (33) (34) (35) and in patients with membranoprolifer- proliferation ofmesangial cells and accumulation ofmesangial matrix.
